Viewing Study NCT04646759

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-26 @ 5:12 AM
Study NCT ID: NCT04646759
Status: RECRUITING
Last Update Posted: 2020-11-30
First Post: 2020-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HR-postitive/HER2-positive metastatic breast cancer View
None fulvestrant View
None Pyrotinib View
None capecitabine View